15Feb Legislators: New system needed to hold university boards accountable Categories: Lower News,VerHeulen News,Webber News Proposal allows voters to weigh in on framework for selecting trusteesFrom left, state Reps. Rob VerHeulen, Jim Lower and Michael Webber testify Thursday before the House Elections and Ethics Committee.State Reps. James Lower, Rob VerHeulen and Michael Webber today said the time is right to consider changing the selection process for future members of the boards governing Michigan State University, Wayne State University and the University of Michigan.The legislators testified before the House Elections and Ethics Committee in support of their three-piece proposal that would bring the three major state universities in line with every other public university in Michigan, where trustee appointments are made by the governor.“When you put the two processes next to each other, the appointment process is better. The candidates go through a thorough vetting process that results in a well-rounded, better-qualified governing board,” said Lower, of Cedar Lake. “It’s time to present it as an option to the voters and allow them to decide if they think it makes sense for the other three public universities as well.”VerHeulen said 12 of Michigan’s 15 public universities currently use the model they have proposed. The majority of other states also rely on a gubernatorial appointment process.“I had a chance to talk to the leadership at Grand Valley State University,” said VerHeulen, of Walker. “They indicated to me that the gubernatorial appointment route has worked very well. Governors of both parties have focused on the mission of the university when making the appointments, avoiding partisan politics that doesn’t necessarily advance the mission of the university.”Webber, of Rochester Hills, said he received similar feedback from Oakland University, located within his House district.“The governors of both political parties in the past have treated the appointments for these 12 university boards in a very professional manner,” Webber said. “This model works very well there, and it works in a lot of other states.”House Joint Resolution DD, introduced by Lower, would abolish the existing governing boards at MSU, U-M and Wayne State, as well as the state school board, on Dec. 31, 2018. On Jan. 1, 2019, the governor would appoint eight members to each board to serve staggered terms.The proposal would be placed on the statewide ballot for voter consideration if HJR DD is approved by two-thirds of both the House and Senate.House Bills 5515 and 5516, introduced by VerHeulen and Webber, update Michigan’s election law and campaign finance act to reflect changes made in HJR DD.The legislation remains under consideration by the House Elections and Ethics Committee.###
Sports broadcaster Eurosport’s Eurosport.com attracted almost 5.6 million daily visitors during the Olympic Games.Of those, 1.2 million came from mobile devices. The online and mobile global audience was 36% higher than its yearly average.With 6.5 million visitors on August 3, Eurosport.com achieved its best ever digital performance, while the English and Spanish markets broke their individual historical records on the web during the Games. The broadcaster said athletics, swimming and tennis were the most followed sports on Eurosport.com. According to the broadcaster, over 3.5 million visitors were driven to its online network via Facebook social readers throughout the 16 days of competition.Between July 28 and August 12, a total of 106 million different TV viewers watched the Olympics on Eurosport.
Reviewed by Kate Anderton, B.Sc. (Editor)Nov 14 2018Over 90% of malign tumors in the head and neck are originated from carcinomas of squamous cells that appear in superficial areas of the oral cavity. Their detection with salivary biomarkers can contribute to their early treatment, before they transform into tumors. Researchers of the Oral Microbiology Research Group of the CEU Cardenal Herrera University (CEU UCH) in Valencia, Spain, have conducted a systematic review and a meta-analysis of the salivary markers that show the highest efficacy for the early detection of oral cancer in different clinical trials. The results have just been published in the Journal of Oral Pathology and Medicine, the official magazine of the International Association of Oral Pathogens in the field of Dentistry, Oral Surgery and Medicine.Related StoriesSugary drinks linked to cancer finds studyBacteria in the birth canal linked to lower risk of ovarian cancerHow cell-free DNA can be targeted to prevent spread of tumorsAccording to Verónica Veses, head researcher of the Group and professor at the Biomedical Sciences Department of the CEU UCH, “detection of this type of squamous cell cancer in the surface of the mouth essentially depends of the visual examination on behalf of oral health professionals. This is why it is important to find new diagnostic methods to help with accurate early detection. Specially if we take into account that oral cancer is the most common of the tumors in the head and neck, and which is increasingly prevalent among the young population due to the consumption of tobacco and alcohol”.Three types of biomarkersThe research team headed by Dr. Veses has conducted a systematic review and a meta-analysis of the clinical trials that have thus far evaluated the efficacy of the three types of salivary biomarkers that are the most promising for the early detection of this type of oral cancer. These salivary markers are two types of cytokines, proteins involved in cellular proliferation and differentiation; two markers that are present in the ribonucleic acid that transfers the genetic code, the messenger RNA or mRNA (DUSP‐1 and S100P); and two more in the micro-RNA (miRNA) of the saliva, but which require further research.Both mRNA biomarkers have shown to be the most efficient for the early detection of oral squamous cell carcinoma and of neck and head cancer, when comparing the results obtained in the 17 clinical trials reviewed during the research. These tests were chosen as appropriate for the study among those published after the year 2000 in the international database Medline and the international registry of clinical trials: the Central Register of Controlled Trials.Research teamThe results are part of the final degree project of UCH CEU Dentistry student Fariah Gaba, under the guidance of professors Verónica Veses and Chirag Sheth, members of the Oral Microbiology Research Group of this university. Fariah Gaba, who has obtained the Extraordinary Degree Prize for her Dentistry studies, is currently working as a dentist in Holland and began her research efforts working on one of the UCH CEU’s research and teaching projects of the Oral Microbiology Group. Source:http://ruvid.org/ri-world/researchers-detect-the-most-efficient-salivary-biomarkers-for-detecting-oral-cancer/
Reviewed by Alina Shrourou, B.Sc. (Editor)Nov 19 2018Glutamate is the major excitatory neurotransmitter in the brain, and the postsynaptic expression level of glutamate receptors is a critical factor in determining the efficiency of information transmission and the activity of the neuronal network. Therefore, glutamate receptor trafficking is critical to the physiological function of human brain circuitry.It is known that KAR-type glutamate receptors are closely related to many neurological disorders. Dr. SHENG Nengyin at the Kunming Institute of Zoology of the Chinese Academy of Sciences has long been devoted to studying the regulation of KAR trafficking. His previous studies have revealed that in neurons the trafficking performance of KAR subunits GluK1 and GluK2 are totally different, and it is the amino acid sequences of their extracelluar domains that determine their distinct trafficking capability.To resolve the molecular machinery, the “Neural Synaptic Mechanism and Function” group led by Dr. SHENG Nengyin, in collaboration with Dr. SHI Yun’s Lab at the Model Animal Research Center of Nanjing University, made serial chimeric GluK1-GluK2 receptors based on their conserved structures. The study was published in Nature Communications.Researchers applied electrophysiological techniques to hippocampal slice cultures to analyze the synaptic responses mediated by these receptors. They unexpectedly found a crucial inhibitory role for the signal peptide in GluK1 trafficking.Signal peptides are N-terminal residues of newly synthesized secretory or membrane proteins. Generally, they are regarded as “cellular address codes” for intracellular trafficking, localization and secretion.When GluK1 signal peptide was replaced by that of GluK2, GluK2 signal peptide reversed the previous synaptic trafficking incapability. The resultant GluK1 (SPGluK2) receptor potentiated synaptic responses similar to wild-type GluK2, and this potentiation was suppressed by coexpressed GluK1 signal peptide in the same neurons.Related StoriesTargeted breast cancer therapy shows ‘encouraging’ resultsLiving with advanced breast cancerResearchers develop DNA nanorobots that target breast cancer cellsFurthermore, they found that the inhibitory function of GluK1 signal peptide requires the presence of the N-terminal domain, since GluK1 successfully trafficked to synapses and neuronal surfaces if the N-terminal domain was replaced with the corresponding sequences of GluK2.Biochemical studies revealed that GluK1 signal peptide directly interacts with its N-terminal domain (ATD). Therefore, the researchers proposed a model whereby the cleaved signal peptide, in a trans manner and behaving as a ligand of GluK1, binds to GluK1 ATD and forms an inhibitory complex regulating GluK1 forward trafficking in neurons.This study has revealed a signal peptide function for glutamate receptor trafficking and uncovered a novel trafficking mechanism for glutamate receptors. It provides the theoretical basis for further study of synaptic transmission and plasticity, as well as the pathological mechanism of related neurological disorders.The human brain has around 10 billion neurons. The neural synapses are the basic connection units transferring information between them. Neurotransmitters, which are released by presynaptic neurons, diffuse into the synaptic cleft and bind to the corresponding receptors on postsynaptic neurons. By doing so, they regulate neuronal activity and accomplish information transmission. Any deregulation of this process is regarded as a leading cause of neurological disorder. Source:http://english.cas.cn/newsroom/research_news/201811/t20181109_201096.shtml
By Dr. Ananya Mandal, MDNov 21 2018A team of researchers from University of Queensland have found that tobacco use is associated with an increased risk of psychotic disorders including schizophrenia.The study titled “Evidence of a Causal Relationship Between Smoking Tobacco and Schizophrenia Spectrum Disorders,” was published in the latest issue of the journal Frontiers in Psychiatry. Image Credit: Sruilk / Shutterstock For this study the team looked at eight long term studies and collated the data available to find the evidence that smoking could be linked to mental illnesses. They team suggests that nicotine in tobacco could play a role in these disorders.According to lead author of the study Associate Professor James Scott this also raises concerns about the rising nicotine use among youngsters in the form of e-cigarettes. He said that those who smoke are at a “two fold” risk of schizophrenia or psychosis as is evident from these studies. He said, “While e-cigarettes reduce some of the harms associated with smoking, governments need to consider their potential to harm the mental health of young people. More research is urgently needed to examine the association between e-cigarette use and psychosis, particularly in adolescents and young adults, until then, liquid nicotine should remain illegal for purchase in Australia without a prescription,” Dr Scott said.The team looked at eight long term cohort studies. They found that six of the eight showed a statistically significant association between tobacco smoking and psychotic disorders or schizophrenic spectrum disorders or SSD. According to authors SSD includes, “schizophrenia, schizophreniform disorder, schizoaffective disorder, delusional disorder, non-affective psychotic disorder, atypical psychosis, psychotic depression, and bipolar mania with psychotic features”. The team adjusted the findings for age, gender, genetic risk, use of other substances such as cannabis, socioeconomic status etc. before coming to the conclusions.Related StoriesWorld No Tobacco Day 2019: Respiratory groups urge to strengthen WHO Framework Convention on Tobacco ControlResearchers find new physical evidence in the brain for types of schizophreniaNeuroscientists use novel technology-based tools to predict schizophreniaTo assess if there was any association, the team used a Bradford Hill Framework which contains nine criteria that can link the exposure to outcome. Of these nine criteria, five were chosen to be highly relevant. All studies were conducted in high income countries. The participants in the studies were followed up for a minimum of 4 years to a maximum of 48 years.Results showed that there was a six fold rise in risk of schizophrenia in heavy smokers as seen from the strength of association. Only one of the eight studies did not show a causal association between smoking and schizophrenia write the researchers. Overall there was a two-fold rise in risk of schizophrenia among smokers, the researchers write.The authors of the study explain that there are around 5000 different chemicals in tobacco smoke but nicotine seems to be the main culprit here. There have been studies that have shown that nicotine is capable of altering the signal system of the brain mainly in the “dopaminergic, cholinergic, and glutamatergic neurotransmitter systems,” they explain. This could negatively influence brain maturation in teenagers and young adults. Further this could cause “strengthening of negative emotional changes and alterations in cognitive functioning,” in adolescents they add and this could possibly lead to mental ailments later in life.Source: https://www.frontiersin.org/articles/10.3389/fpsyt.2018.00607/full
Opaque methodology: Without further details in the public domain, the methodology used by The Global Fund in calculating the lives it has saved cannot be verified or reproduced by external researchers. More transparency in its modeling methodology, the authors argue, would build confidence in the organization’s claims among funders and external researchers. (Since a draft of the analysis was shared, The Global Fund has revised its methodology statement on its website, but the authors call for further improvements). Distinguishing The Global Fund’s institutional impact from the impact of the broader partnership:The analysis suggests The Global Fund results report conflates the impact of The Global Fund “partnership”—encompassing other donors, NGOs, and country governments—with the impact of The Global Fund as a standalone institution with an annual budget of roughly $4bn. The authors argue that distinctly separating the activities of The Global Fund from activities carried out by partner organizations would make its impact much clearer. For example, domestic policies in large countries such as India and South Africa have led to significant investments to tackle tuberculosis and HIV;in addition, economic growth is estimated to be responsible for a significant reduction in maternal and child deaths from 1990-2010. The impact of both of these external factors is not distinguished in The Global Fund’s claim of saving 27 million lives. Unreliable data: Much of the data is from countries where statistical systems are weak or non-existent. The authors acknowledge the difficulties of working with these restraints but reiterate their call for data to be collected in rigorous performance evaluations to supplement the results of modeling exercises. Reviewed by James Ives, M.Psych. (Editor)Jan 25 2019The Global Fund to Fight AIDS, Tuberculosis and Malaria (‘The Global Fund’) asserts they and their partners have saved 27 million lives—but more rigorous evidence and data is needed to back up that claim, according to a new analysis published in The Lancet this week.The analysis, by Dr Rocco Friebel of The London School of Economics and Political Science (LSE) and Rachel Silverman, Amanda Glassman, and Dr Kalipso Chalkidou of the Center for Global Development (CGD), calls on The Global Fund to publish more robust data and be more transparent in its official impact reports, and highlights ways the financing organization can improve its evidence base.The authors note The Global Fund is likely to have had a positive impact, having distributed over $39 billion of aid funding around the world, but suggest improvements the organization and others could adopt for their impact measurement and reporting, including: Related StoriesReversing drug resistance in tuberculosis bacteriaEngineers crack the code to quickly diagnose anti-malarial drug resistanceScorpion venom contains compounds that could help fight Staph and tuberculosis bacteriaCommenting on the analysis, Dr Rocco Friebel, lead author and Assistant Professor of Health Policy at LSE, said: “There is no doubt organizations like The Global Fund do great work but to ensure continuous donor investment they need to be more open and honest with their reporting,””The methods and underlying data of the modeling exercise conducted by The Global Fund and others should be released and subject to public scrutiny. The organization should be clear about its methodology, share relevant data and open itself up to peer review. Taking these steps toward openness will instill confidence in partners and lead to more sustainable fundraising for aid relief.”Amanda Glassman, chief operating officer at the Center for Global Development, said: “Funders have tough choices to make, and a more grounded and evidence-based assessment of The Global Fund’s actual impacts would help the organization make its case in the difficult replenishment cycle ahead.””Our concerns are not new,” added Kalipso Chalkidou, director of global health policy at the Center for Global Development. “For years, we’ve called for The Global Fund to stand on firmer ground when estimating the lives its work has saved. The Global Fund does important work, and in order to make sure everyone has confidence in that work, it’s time for the organization to take our calls for transparency seriously.”Rachel Silverman, policy fellow at the Center for Global Development, said .”Global health partnerships, including The Global Fund, hold a position of immense responsibility as the stewards of scarce aid dollars. To best serve the populations in need of that assistance—and to attract additional resources in the upcoming replenishment cycle—we hope that The Global Fund and other funders will embrace the highest standards of evidence and accountability.” The analysis also details current shortcomings of The Global Fund’s evaluations, including: More rigorous performance evaluations: Rather than relying on theoretical, modeled results alone, more rigorous performance evaluations would help assess whether The Global Fund’s grant recipients are delivering the services and products being financed. Structuring grants to prioritize evidence from the start: Taking this step would help ensure the most effective projects and products are being funded. Expanding the scope of impact evaluation: As well as expanding evaluations, The Global Fund should refocus on areas where evidence is most needed, such as particularly large projects and programs using new and untested strategies. Publishing the data and models used to estimate impact: Where empirical evidence isn’t available, The Global Fund should at least make the data and models used to estimate impact available to researchers and the public. Source:http://www.lse.ac.uk/
We were surprised by the number of nurses potentially suffering from common sleep disorders, most notably, chronic insomnia and shift work disorder.”Lead author Francis Christian, M.D., a second-year fellow at the University of Oklahoma Health Sciences Center in Oklahoma City Reviewed by James Ives, M.Psych. (Editor)Jun 10 2019According to preliminary results of a new study, there is a high prevalence of insufficient sleep and symptoms of common sleep disorders among medical center nurses.Results show that 49% of participating nurses at an academic medical center averaged less than 7 hours of sleep per night, and the overall average nightly sleep time was 6.6 hours. Symptoms consistent with chronic insomnia were identified in 31% of nurses, and excessive daytime sleepiness was found in 4.5% of them. Twenty-seven percent of nurses used medications to help them sleep, and 13% reported using medications to stay awake. Symptoms indicative of shift work disorder were present in 31% of nurses. About 18.5% of nurses also had a moderate-to-severe risk for obstructive sleep apnea. Related StoriesSleep disorders in patients with low back pain linked to increased healthcare visits, costsSleep quality linked to memory problems in new studySleep makes synapses ready for new learningThe American Academy of Sleep Medicine recommends that adults should sleep 7 or more hours per night on a regular basis to promote optimal health. According to the authors, nearly 100,000 deaths are estimated to occur each year in U.S. hospitals due to medical errors, and sleep deprivation and sleep disorders are significant contributors to this risk.The study involved an online survey of 1,165 nurses at a tertiary care medical center. Questions asked about topics such as their sleep schedule and medications. Questionnaires such as the STOP-BANG and Epworth Sleepiness Scale were used to assess the nurses for sleep disorder symptoms.”Nurses are at increased risk for circadian rhythm sleep-wake disorders such as shift work disorder,” said Christian. “Recognition needs to take place so that we can screen appropriately and make scheduling modifications to help alleviate the burden of shift work disorder among nurses.”The research abstract was published recently in an online supplement of the journal Sleep and will be presented Monday, June 10, in San Antonio at SLEEP 2019, the 33rd annual meeting of the Associated Professional Sleep Societies LLC (APSS), which is a joint venture of the American Academy of Sleep Medicine and the Sleep Research Society.Source:American Academy of Sleep MedicineJournal reference:Christian, F. et al. (2019) Sleep Health of Nursing Staff in an Academic Medical Center: Results of a Survey Study. Sleep. doi.org/10.1093/sleep/zsz067.628.
Explore further Facebook shared user information with dozens of hardware and software makers, as well as application developers, well after it said it cut off outside companies’ access to the data in 2015. ©2018 USA Today Distributed by Tribune Content Agency, LLC. The setups were described in 747 pages of documents submitted to the House Energy and Commerce Committee late Friday in response to hundreds of questions lawmakers had asked company executives.The disclosures come amid widening scrutiny of how well Facebook protects the personal information of the network’s users and their friends.The social networking giant said it made the special arrangements so hardware and software makers could ensure Facebook worked on their devices and operating systems and application developers had time to comply with the company’s stricter access policies.All told, 52 hardware and software makers—including Apple, Blackberry, Amazon and Microsoft—had access to the data. But the list also includes Chinese firms such as Huawei and Alibaba, some of which generated national security concerns.Facebook said it has ended 38 of the 52 partnerships. It said it will shut down an additional seven by the end of July and another one by the end of October. Among the handful that will continue beyond that are those with Amazon, Apple and Alibaba.”We engaged companies to build integrations for a variety of devices, operating systems and other products where we and our partners wanted to offer people a way to receive Facebook or Facebook experiences,” the company said in the documents. “These integrations were built by our partners, for our users, but approved by Facebook.”The company said it forged the relationships before the spread of powerful iPhone and Android operating systems that have allowed consumers to easily access the web. Back then, people “went online using a wide variety of text-only phones, feature phones and early smartphones with varying capabilities,” Facebook said.Facebook also gave 61 app developers about six months beyond a May 2015 deadline to comply with more restrictive access to Facebook’s computer programming code. Those developers included companies such as AOL, Audi, Panasonic and Hinge, a dating app, which also had information on users’ friends, such as phone numbers.The deals with developers and hardware and software makers were reported by The Wall Street Journal and The New York Times early last month, but the new documents detail the number of companies involved and the extent of the setups.Facebook has been under fire since it was revealed earlier this year that a political ad targeting firm, Cambridge Analytica, purchased data on up to 87 million users from Facebook without their consent. Facebook CEO Mark Zuckerberg appeared before Congress in April and apologized for not doing enough to protect user data.The Federal Trade Commission is investigating whether the company’s actions violated a 2011 consent decree barring it from making misrepresentations about the privacy or security of consumers’ personal information. Facebook says Chinese phone makers got access to data (Update) Credit: CC0 Public Domain Citation: Facebook reveals special data-sharing deals to Congress (2018, July 3) retrieved 18 July 2019 from https://phys.org/news/2018-07-facebook-reveals-special-data-sharing-congress.html This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
7 Odd Things That Raise Your Risk of Cancer (and 1 That Doesn’t) Colorful But Deadly: Images of Brain Cancer 7 Side Effects of Cancer Treatment, and How to Cope with Them Originally published on Live Science.by Taboolaby TaboolaSponsored LinksSponsored LinksPromoted LinksPromoted LinksYou May LikeVikings: Free Online GamePlay this for 1 min and see why everyone is addicted!Vikings: Free Online GameUndoTruthFinder People Search SubscriptionOne Thing All Liars Have in Common, Brace YourselfTruthFinder People Search SubscriptionUndohear.comThese German hearing aids are going viralhear.comUndoGundry MD Total Restore SupplementU.S. Cardiologist: It’s Like a Pressure Wash for Your InsidesGundry MD Total Restore SupplementUndoYahoo SearchYou’ve Never Seen Luxury Like This On A Cruise Ship. Search Luxury Mediterranean CruisesYahoo SearchUndoNature's BlendNever Let Your Dog Eat These 3 FoodsNature’s BlendUndo A simple cold virus could wipe out tumors in a form of bladder cancer, a small new study suggests. Though the idea of using viruses to fight cancer isn’t new, this is the first time a cold virus effectively treated an early-stage form of bladder cancer. In one patient, it eliminated a cancerous tumor, the group reported July 4 in the journal Clinical Cancer Research. A group of researchers conducted an early-stage clinical trial in which they infected 15 bladder cancer patients with coxsackievirus A21, which is one of the viruses that cause the common cold. Coxsackievirus is not a genetically modified virus; it’s “something that occurs in nature,” said senior author Hardev Pandha, a professor of medical oncology at the University of Surrey in England. [Exercise May Reduce the Risk of These 13 Cancers]Headbutting Tiny Worms Are Really, Really LoudThis rapid strike produces a loud ‘pop’ comparable to those made by snapping shrimps, one of the most intense biological sounds measured at sea.Your Recommended PlaylistVolume 0%Press shift question mark to access a list of keyboard shortcutsKeyboard Shortcutsplay/pauseincrease volumedecrease volumeseek forwardsseek backwardstoggle captionstoggle fullscreenmute/unmuteseek to %SPACE↑↓→←cfm0-9接下来播放Why Is It ‘Snowing’ Salt in the Dead Sea?01:53 facebook twitter 发邮件 reddit 链接https://www.livescience.com/65908-cold-virus-might-treat-bladder-cancer.html?jwsource=cl已复制直播00:0000:3500:35 The researchers gave the patients the virus through catheters that the patients already had inserted for other treatments. They left the virus-filled catheter in for an hour to pump the fluids into the bladder and repeated this treatment. Then, the patients underwent surgery to remove what was left of their bladder tumors. In one patient, the virus completely destroyed the tumor. In all of the other patients, the researchers found evidence that the virus had damaged the tumors and had spurred the immune system to send an army of immune cells to the tumors. None of the patients had any significant side effects, Pandha said. Researchers thought this method would work because the outer membranes of cancerous bladder cells contain a gateway for the coxsackievirus: a molecule called ICAM-1. Because healthy cells don’t carry this molecule, the coxsackievirus doesn’t attack them. Once the virus gets into the cell, it hijacks the cell’s machinery and ends up killing it. Even more cancer cells die when the immune cells are recruited. ICAM-1 is also expressed by other cancer cells, and coxsackievirus has, in fact been previously shown to be effective in treating very advanced bladder cancer and other cancers, such as melanoma, Pandha said. Even so, this is still an early-stage trial, and there’s still a long way to go before the method can be used in treatment, Pandha said. “This would be the foundation for much larger studies where we’d build on this,” he said. Newer studies will try to make the treatment more effective and stop the cancer from coming back, he added. Unfortunately, just getting a common cold won’t treat the cancer on its own. Pandha’s team gave a much higher dose of the virus than you would get if someone coughed on you and you got sick, for example. Interestingly, the patients who were given the virus through the catheter did not get cold symptoms. “I agree that [such viruses are] good therapeutic target[s]” for certain types of cancers, like bladder cancer, said Grant McFadden, director of the Biodesign Center for Immunotherapy, Vaccines and Virotherapy at Arizona State University, who was not a part of the study. But he noted that many studies have looked at whether viruses can target cancer cells. In fact, a host of viruses have been studied for attacking bladder cancer, specifically. It’s likely that many viruses will work well to treat bladder cancer and at least some tumor-destroying viruses “will get approved for use in humans,” McFadden told Live Science. “But this paper isn’t really new or innovative.” In fact, the idea of using viruses to treat cancer goes back nearly 100 years, Pandha said, but only in the past decade or so has it gained momentum. Editor’s note: This article was updated. Only a couple of the authors (not Pandha) are employed by Viralytics, a Merck-owned biotech company that is developing viral-based cancer treatments.